Vanguard Investments Australia
CRMD icon

Vanguard Investments Australia’s CorMedix CRMD Stock Holding History

Vanguard Investments Australia’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Hold
15,886
– – ﹤0.01% 2271
2026
Q1 		$108K Buy
+15,886
New +$117K ﹤0.01% 2258

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Investments Australia's CRMD Position: Q2 2026 in Review

Vanguard Investments Australia held its CorMedix (CRMD) position steady in Q2 2026 at 15,886 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

Vanguard Investments Australia first reported a position in CRMD in Q1 2026 and has held it in 2 quarters since. 175 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Vanguard Investments Australia held 15,886 shares of CorMedix worth $125K as of Q2 2026.
  • Vanguard Investments Australia left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2271 holding.
  • Vanguard Investments Australia first reported a position in CorMedix in Q1 2026 and has held it in 2 quarters since.
  • 175 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.